Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
BMC Nephrology|October 8, 2020
Clinical application of drug sensitive gene detection in postoperative instillation for non-muscle invasive bladder cancerZhenlong Wang, Hui Tang, Yuquan Xue, et al.
The Journal of International Medical Research|April 22, 2021
Elevated free testosterone levels and reduced very low-density lipoprotein levels in men with lifelong premature ejaculation: a preliminary studyJun Zhao, Yubo Ma, Xiaoqiang Zhai, et al.
Cancer Gene Therapy|November 20, 2021
Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasisDong Zhang, Xiao-Jie Yang, Qi-Dong Luo, et al.
Journal of Bioenergetics and Biomembranes|March 9, 2021
MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axisXiaoqiang Zhai, Yan Wu, Dong Zhang, et al.
Journal of Cellular and Molecular Medicine|August 7, 2021
Effects of a gamma-secretase inhibitor of notch signalling on transforming growth factor β1-induced urethral fibrosisShanlong Huang, Delai Fu, Ziyan Wan, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|April 19, 2018
Retroperitoneal Laparoscopic Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1 Renal Hilar Tumor: Comparison of Perioperative Characteristics and Short-Term Functional and Oncologic OutcomesChuance Yang, Zhenlong Wang, Shanlong Huang, et al.
Critical Reviews in Eukaryotic Gene Expression|January 19, 2021
The Significance of Detection of Circulating Tumor Cells and Beclin1 in Peripheral Blood of Patients with Renal Cell CarcinomaPeng Zhang, Zhenlong Wang, Xiaojie Yang, et al.
Current Molecular Medicine|March 5, 2019
Association of ATG7 Polymorphisms and Clear Cell Renal Cell Carcinoma RiskZhenlong Wang, Lei Tao, Yuquan Xue, et al.
Scientific Reports|April 28, 2023
MMP9 and TYROBP affect the survival of circulating tumor cells in clear cell renal cell carcinoma by adapting to tumor immune microenvironmentLingyu Guo, Tian An, Haibin Zhou, et al.
Acta Pharmacologica Sinica|June 28, 2016
Dendritic cells serve as a "Trojan horse" for oncolytic adenovirus delivery in the treatment of mouse prostate cancerZhao-Lun Li, Xuan Liang, He-Cheng Li, et al.
Pageof 14